Molecular and Population Genetics Laboratory and Oxford NIHR Comprehensive Biomedical Research Centre, Nuffield Department of Clinical Medicine, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Mutagenesis. 2012 Mar;27(2):219-23. doi: 10.1093/mutage/ger070.
Despite their prime candidate status, polymorphisms near genes involved in DNA repair or in other functions related to genome stability have been conspicuously under-represented in the significant associations reported from genome-wide association studies (GWAS) of cancer susceptibility. In this study, we assessed a set of single-nucleotide polymorphisms (SNPs) near 157 DNA repair genes in three colorectal cancer (CRC) GWAS. Although no individual SNP showed evidence of association, the set of SNPs as a whole was associated with colorectal cancer risk. When candidate SNPs were examined, our data did not support most of the previously reported associations with CRC susceptibility, an exception being an effect of the MLH1 promoter SNP -93G>A (rs1800734). Rare variants in CHEK2 (I157T and possibly del1100C) also appear to be associated with CRC risk. Overall, the absence to date of disease-associated DNA repair SNPs in cancer GWAS may be explained by a combination of the following: (i) many loci with individually very small effects on risk; (ii) rare alleles of moderate effect and (iii) subgroups of CRC, such as those with microsatellite instability, associated with specific variants. It will be particularly intriguing to determine whether any GWAS across cancer types identify DNA variants that predispose to cancers of more than one site.
尽管它们是主要的候选者,但在癌症易感性的全基因组关联研究 (GWAS) 报告的显著关联中,涉及 DNA 修复或与基因组稳定性相关的其他功能的基因附近的多态性却明显缺失。在这项研究中,我们评估了三个结直肠癌 (CRC) GWAS 中 157 个 DNA 修复基因附近的一组单核苷酸多态性 (SNP)。虽然没有单个 SNP 显示出关联的证据,但整个 SNP 集与结直肠癌风险相关。当检查候选 SNP 时,我们的数据不支持大多数先前报道的与 CRC 易感性相关的关联,除了 MLH1 启动子 SNP -93G>A(rs1800734)的作用。CHEK2(I157T 和可能的 del1100C)中的稀有变体似乎也与 CRC 风险相关。总体而言,迄今为止,癌症 GWAS 中没有与疾病相关的 DNA 修复 SNP,可能是以下因素的综合作用:(i) 许多对风险影响非常小的位点;(ii) 中等效应的罕见等位基因;(iii) 与特定变体相关的特定 CRC 亚组,例如微卫星不稳定。特别有趣的是要确定是否有任何跨癌症类型的 GWAS 可以确定易患多种部位癌症的 DNA 变体。